Biolytica
Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform integrating biological and lifestyle data into preventive healthcare and longevity solutions for healthcare providers, insurance carriers, and wellness clinics on a subscription basis.
- Company typePrivate
- Founded2023
- HeadquartersZug, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Biolytica does
Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform designed to integrate diverse biological and lifestyle data into actionable health insights for preventive healthcare and longevity use cases. The company is headquartered in Switzerland (Zug/Zurich), was founded in 2021, and operates with a workforce of 11-50 employees. Its target customers span three B2B segments: healthcare providers (hospitals and clinics seeking integrated patient data), insurance companies (using biological data for risk assessment and wellness-linked products), and wellness clinics (delivering personalized client programs). The company pursues a horizontal segmentation approach across these verticals.
The NEXUS platform is the sole core product. Biolytica describes its underlying AI as generative_ai applied to consolidating fragmented biological and lifestyle data streams into health solutions; no proprietary models, patents, or third-party benchmarks are disclosed. The revenue model is subscription-based recurring, sold to enterprise B2B clients, but pricing is not publicly disclosed and no customer logos, case studies, or contract values have been disclosed in the available data.
Biolytica has raised a single seed round of CHF 5.25 million (approximately US$5.8 million) from the Maximon Longevity Co-Investment Fund in May 2023. The company stated an aspiration for mid-7-figure annual revenue by year-end 2023, but no actual revenue figure has been reported. Leadership comprises Dr. Rob Konrad Maciejewski (CEO) and Marc P. Bernegger (Founder). A material caveat: the company's primary web domain biolytica.com appears listed for resale on a third-party domain marketplace (Atom.com), which raises concerns about the company's control of its primary digital asset and warrants verification in any diligence process.
Biolytica firmographics
Firmographics- Name
- Biolytica
- Legal name
- Biolytica
- Website
- https://biolytica.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform integrating biological and lifestyle data into preventive healthcare and longevity solutions for healthcare providers, insurance carriers, and wellness clinics on a subscription basis.
- Ownership category
- akta.pro rank
Biolytica industry classification
Industry- Product category
- Health Data Analytics Platform
- NAICS
- Social Assistance (624), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)
- akta.pro secondary industries
- Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ), Behavioral Health & Substance Use Remote Monitoring (HLACAFAD)
Keywords
Where Biolytica is headquartered
LocationHeadquarters
- HQ city
- Zug
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Biolytica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Data-driven health solutions: Biolytica generates revenue by offering AI-driven data solutions to healthcare providers, insurance companies, and wellness clinics. The platform integrates biological and lifestyle data to provide actionable health insights.
Go-to-market motion1 record
Biolytica product offering
Product offeringCore offering
Biolytica develops and sells NEXUS, an AI-driven health data platform that integrates diverse biological and lifestyle data to generate preventive healthcare and longevity solutions. The platform is offered to healthcare providers, insurance companies, and wellness clinics to support personalized health insights, risk assessment, and wellness program design. Revenue is generated via a subscription-based recurring model targeted at B2B customers.
Product overview
Biolytica offers a single unified AI-driven health data platform called NEXUS. The platform integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with a focus on preventive healthcare and longevity.
Differentiator
Problem solved
Functional benefit
Brands
- NEXUS: AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with focus on preventive healthcare and longevity.
Products and services
- NEXUS AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, focused on preventive healthcare and longevity.
Companies that use Biolytica
Customer profileSegments3 records
Ideal customer profiles3 records
Biolytica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Biolytica partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Biolytica competitors and assessment
Company assessmentDirect peers
- Function Health: Function Health is a direct competitor offering membership-based preventive health with comprehensive blood biomarker testing and AI-driven insights — very similar to Biolytica's value proposition of integrating biological data for personalized health optimization.
- InsideTracker: InsideTracker integrates blood, DNA, wearable, and lifestyle data to deliver personalized health and longevity recommendations. It is one of the closest direct peers to Biolytica's NEXUS platform in terms of integrating diverse biological data sources for preventive insights.
- Viome Life Sciences: Viome uses AI to analyze microbiome and other biological data to generate personalized nutrition and health recommendations. It competes directly in the AI-driven, data-aggregated preventive health space where Biolytica plays.
- Prenuvo: Prenuvo offers whole-body MRI screening combined with AI-driven health insights for preventive and longevity-focused consumers. It competes with Biolytica for the same health-conscious, data-driven preventive health customer base.
- Fountain Life: Fountain Life provides AI-enabled preventive health diagnostics and longevity-focused health programs. It is a direct competitor in the preventive/longevity health data and diagnostics space, with similar target customers.
Broad incumbents
- Thorne HealthTech: Thorne combines supplements with at-home health testing and a digital platform to deliver personalized wellness. It overlaps with Biolytica in the longevity/preventive health data space but operates a much broader product portfolio including supplements.
- Human Longevity Inc. Human Longevity Inc. offers comprehensive genomic and clinical data integration for longevity-focused preventive health. It is a more established incumbent with broader capabilities than Biolytica in the same longevity/health-data aggregation space.
- 23andMe: 23andMe is a consumer genetic testing company that has expanded into health-risk reporting and research platforms based on aggregated genetic data. It is comparable to Biolytica in the consumer-facing biological data aggregation model, though focused narrowly on genomics.
Emerging players
- Elysium Health: Elysium Health develops longevity-focused supplements and consumer health products grounded in cellular biology research. It is a partial peer — operating in the longevity space with a different monetization model (products vs. data platform) but targeting overlapping consumers.
- Ezra: Ezra offers AI-powered full-body MRI screening for early cancer detection and preventive health. It overlaps with Biolytica's preventive/longevity positioning but is narrower in scope (imaging-focused).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key highlights6 records
Customer concentration
Biolytica social profiles
Digital presenceBiolytica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biolytica leadership team
Management profileNumber of profiles
Profiles2 records
Biolytica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biolytica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biolytica
What does Biolytica do?
Biolytica develops and sells NEXUS, an AI-driven health data platform that integrates diverse biological and lifestyle data to generate preventive healthcare and longevity solutions. The platform is offered to healthcare providers, insurance companies, and wellness clinics to support personalized health insights, risk assessment, and wellness program design. Revenue is generated via a subscription-based recurring model targeted at B2B customers.
Is Biolytica a public or private company?
Biolytica is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biolytica founded?
Biolytica was founded in 2023. It employs 11 to 50 people.
Where is Biolytica based?
Biolytica is headquartered in Zug, Switzerland, in the Europe region.
How does Biolytica make money?
One revenue line is on record: data-driven health solutions.
Who are Biolytica's main competitors?
Direct peers on record are Function Health, InsideTracker, Viome Life Sciences, Prenuvo and Fountain Life. Broad incumbents are Thorne HealthTech, Human Longevity Inc. and 23andMe. Emerging players are Elysium Health and Ezra.
Does Biolytica have an API?
No public API is recorded for Biolytica.
What industry is Biolytica in?
Biolytica's product category is Health Data Analytics Platform. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLACAFAJ, Patient App, Adherence & Engagement for RPM Programs. Its NAICS code is 624 and its SIC code is 7372.